Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HODGKIN LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchWithdrawnNCT05015972
What this trial is testing

UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies

Who this might be right for
B-cell Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Early research (Phase 1)Study completedNCT01969695
What this trial is testing

An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
AbbVie 11
Large-scale testing (Phase 3)Looking for participantsNCT05820841
What this trial is testing

Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma

Who this might be right for
Large B-cell LymphomaDiffuse Large B Cell Lymphoma
Universität des Saarlandes 330
Testing effectiveness (Phase 2)Looking for participantsNCT05092451
What this trial is testing

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Who this might be right for
B-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Ended earlyNCT00274651
What this trial is testing

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

Who this might be right for
Cutaneous T-Cell LymphomaPeripheral T-Cell LymphomaNon-Hodgkin's Lymphoma
Valerio Therapeutics 53
Large-scale testing (Phase 3)Ended earlyNCT00920153
What this trial is testing

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

Who this might be right for
Lymphoma
French Innovative Leukemia Organisation 442
Testing effectiveness (Phase 2)Ended earlyNCT00301795
What this trial is testing

Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Stage III Grade 1 Follicular LymphomaStage III Grade 2 Follicular LymphomaStage III Grade 3 Follicular Lymphoma+3 more
National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Study completedNCT00055653
What this trial is testing

Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT01969669
What this trial is testing

Assess the Effect of Ketoconazole on the Metabolism of ABT-199

Who this might be right for
Non-Hodgkin's Lymphoma
AbbVie 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07517705
What this trial is testing

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
University of Nebraska 50
Testing effectiveness (Phase 2)Study completedNCT02890602
What this trial is testing

Erythropoietin for Management of Anemia Caused by Chemotherapy

Who this might be right for
Diffuse Large B-cell Lymphoma
Kosin University Gospel Hospital 53
Early research (Phase 1)Study completedNCT02603445
What this trial is testing

Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL

Who this might be right for
Follicular Lymphoma, Mantle Cell Lymphoma
Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Study completedNCT05507645
What this trial is testing

ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)

Who this might be right for
Ischemic StrokeMildThrombosis
Beijing Tiantan Hospital 1,446
Testing effectiveness (Phase 2)Study completedNCT02853370
What this trial is testing

Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma

Who this might be right for
Marginal Zone B-cell Lymphoma
International Extranodal Lymphoma Study Group (IELSG) 78
Testing effectiveness (Phase 2)Looking for participantsNCT06848569
What this trial is testing

Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study

Who this might be right for
Classical Hodgkin Lymphoma
Sun Yat-sen University 73
Early research (Phase 1)Study completedNCT00944905
What this trial is testing

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Who this might be right for
Renal Cell CarcinomaNon-hodgkin's Lymphoma
Bristol-Myers Squibb 46
Large-scale testing (Phase 3)Looking for participantsNCT07011056
What this trial is testing

A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Recurrent and Refractory Diffuse Large B-cell Lymphoma
Chengdu Zenitar Biomedical Technology Co., Ltd 390
Early research (Phase 1)Ended earlyNCT02588456
What this trial is testing

Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
University of Pennsylvania 5
Post-approval studies (Phase 4)Not Yet RecruitingNCT06956092
What this trial is testing

Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

Who this might be right for
B Cell Lymphoma (BCL)
Zhengzhou University 40
Testing effectiveness (Phase 2)Study completedNCT01404936
What this trial is testing

Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 35
Next Page